Home / Publications / New hybrid furoxan structures with antiaggregant activity

New hybrid furoxan structures with antiaggregant activity

Alexander Aleksandrovich Larin
Nadezhda Evgenievna Ustyuzhanina 1
Nadezhda Evgenievna Ustyuzhanina
Marina Leonidovna Gening 1
Marina Leonidovna Gening
Nikolay Eduardovich Nifantiev 1
Nikolay Eduardovich Nifantiev
Nina Nikolaevna Makhova 1
Nina Nikolaevna Makhova
Published 2018-11-01
CommunicationVolume 28, Issue 6, 595-597
21
Share
Cite this
GOST
 | 
Cite this
GOST Copy
Larin A. A. et al. New hybrid furoxan structures with antiaggregant activity // Mendeleev Communications. 2018. Vol. 28. No. 6. pp. 595-597.
GOST all authors (up to 50) Copy
Larin A. A., Fershtat L. L., Ustyuzhanina N. E., Gening M. L., Nifantiev N. E., Makhova N. N. New hybrid furoxan structures with antiaggregant activity // Mendeleev Communications. 2018. Vol. 28. No. 6. pp. 595-597.
RIS
 | 
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mencom.2018.11.010
UR - https://mendcomm.colab.ws/publications/10.1016/j.mencom.2018.11.010
TI - New hybrid furoxan structures with antiaggregant activity
T2 - Mendeleev Communications
AU - Larin, Alexander Aleksandrovich
AU - Fershtat, Leonid Leonidovich
AU - Ustyuzhanina, Nadezhda Evgenievna
AU - Gening, Marina Leonidovna
AU - Nifantiev, Nikolay Eduardovich
AU - Makhova, Nina Nikolaevna
PY - 2018
DA - 2018/11/01
PB - Mendeleev Communications
SP - 595-597
IS - 6
VL - 28
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors) Copy
@article{2018_Larin,
author = {Alexander Aleksandrovich Larin and Leonid Leonidovich Fershtat and Nadezhda Evgenievna Ustyuzhanina and Marina Leonidovna Gening and Nikolay Eduardovich Nifantiev and Nina Nikolaevna Makhova},
title = {New hybrid furoxan structures with antiaggregant activity},
journal = {Mendeleev Communications},
year = {2018},
volume = {28},
publisher = {Mendeleev Communications},
month = {Nov},
url = {https://mendcomm.colab.ws/publications/10.1016/j.mencom.2018.11.010},
number = {6},
pages = {595--597},
doi = {10.1016/j.mencom.2018.11.010}
}
MLA
Cite this
MLA Copy
Larin, Alexander Aleksandrovich, et al. “New hybrid furoxan structures with antiaggregant activity.” Mendeleev Communications, vol. 28, no. 6, Nov. 2018, pp. 595-597. https://mendcomm.colab.ws/publications/10.1016/j.mencom.2018.11.010.

Abstract

A series of functionalized furoxans was synthesized, and their effect on the platelet aggregation was estimated using a set of inducers. New hybrid structures comprising the furoxan ring and glycolic or acetylsalicylic acid motifs effectively inhibit aggregate formation induced by adenosine diphosphate and adrenaline. Studies of their NO-donor ability showed that their antiplatelet effects were mainly independent of the NO action.

References

3.
10.1016/j.mencom.2018.11.010_bibe0020
Tetik
Clin. Appl. Thromb. Hemost., 2010
4.
Antiplatelet Effects of Ticlopidine Are Reduced in Experimental Hypercholesterolemia
Hohlfeld T., Scharnowski F., Braun M., Schrör K.
Thrombosis and Haemostasis, 1994
5.
10.1016/j.mencom.2018.11.010_bibe0030
Verstraete
Drugs Today, 1993
6.
A new class of furoxan derivatives as NO donors: mechanism of action and biological activity
Ferioli R., Folco G.C., Ferretti C., Gasco A.M., Medana C., Fruttero R., Civelli M., Gasco A.
British Journal of Pharmacology, 1995
7.
The Furoxan System: Design of Selective Nitric Oxide (NO) Donor Inhibitors of COX-2 Endowed with Anti-Aggregatory and Vasodilating Activities
Del Grosso E., Boschi D., Lazzarato L., Cena C., Di Stilo A., Fruttero R., Moro S., Gasco A.
Chemistry and Biodiversity, 2005
9.
Synthesis and Preliminary Evaluation of N-Oxide Derivatives for the Prevention of Atherothrombotic Events
Rosseto L., Pires M., Melchior A., Bosquesi P., Pavan A., Marcondes S., Chung M., Santos J.
Molecules, 2015
10.
Ananikov V.P., Galkin K.I., Egorov M.P., Sakharov A.M., Zlotin S.G., Redina E.A., Isaeva V.I., Kustov L.M., Gening M.L., Nifantiev N.E.
Mendeleev Communications, 2016
12.
Ananikov V.P., Eremin D.B., Yakukhnov S.A., Dilman A.D., Levin V.V., Egorov M.P., Karlov S.S., Kustov L.M., Tarasov A.L., Greish A.A., Shesterkina A.A., Sakharov A.M., Nysenko Z.N., Sheremetev A.B., Stakheev A.Y., et. al.
Mendeleev Communications, 2017
13.
Zlotin S.G., Churakov A.M., Dalinger I.L., Luk’yanov O.A., Makhova N.N., Sukhorukov A.Y., Tartakovsky V.A.
Mendeleev Communications, 2017
16.
Ustyuzhanina N.E., Fershtat L.L., Gening M.L., Nifantiev N.E., Makhova N.N.
Mendeleev Communications, 2016
17.
K. Schönafinger and H. Bohn, Patent US 5486531, 1996.
18.
Cardiovascular actions of the furoxan CAS 1609, a novel nitric oxide donor
Bohn H., Brendel J., Martorana P.A., Schönafinger K.
British Journal of Pharmacology, 1995
19.
Studies of the potential genotoxic effects of furoxans: The case of CAS 1609 and of the water-soluble analogue of CHF 2363
Balbo S., Lazzarato L., Di Stilo A., Fruttero R., Lombaert N., Kirsch-Volders M.
Toxicology Letters, 2008
20.
Ustyuzhanina N.E., Fershtat L.L., Gening M.L., Nifantiev N.E., Makhova N.N.
Mendeleev Communications, 2018
21.
Synthesis and vasodilating properties of N-alkylamide derivatives of 4-amino-3-furoxancarboxylic acid and related azo derivatives
Ovchinnikov I.V., Kulikov A.S., Makhova N.N., Tosco P., Di Stilo A., Fruttero R., Gasco A.
Il Farmaco, 2003
22.
Lamifiban
Dooley M., Goa K.L.
Drugs, 1999
23.
Ovchinnikov I.V., Blinnikov A.N., Makhova N.N., Khmel’nitskii L.I.
Mendeleev Communications, 1995
24.
Aminofuroxane. 1. Synthese und Struktur
Gagneux A.R., Meier R.
Helvetica Chimica Acta, 1970
25.
Kulikov A.S., Larin A.A., Fershtat L.L., Anikina L.V., Pukhov S.A., Klochkov S.G., Struchkova M.I., Romanova A.A., Ananyev I.V., Makhova N.N.
Arkivoc, 2017
26.
ADP-lnduced Platelet Activation
Puri R.N., Colman R.W., Liberman M.A.
Critical Reviews in Biochemistry and Molecular Biology, 1997
27.
Role of Platelets and Antiplatelet Therapy in Cardiovascular Disease
Ueno M., Kodali M., Tello-Montoliu A., Angiolillo D.J.
Journal of Atherosclerosis and Thrombosis, 2011